| HOME >> MEDICINE >> TECHNOLOGY |
160,850Research and development
21,972
19,059
41,712
36,973Amortization of acquired intangible assets
2,573
2,130
4,604
3,975Donation to Foundation
-
1,000
1,000
2,000Total operating expenses
116,126
106,283
223,687
203,798Income from operations
69,873
57,922
136,266
110,585Other income (expenses), net:Interest income (expense), net
6,005
3,166
11,102
5,290Other, net
3,043
2,009
8,106
5,127Total other income (expenses), net
9,048
5,175
19,208
10,417Income before income taxes
78,921
63,097
155,474
121,002Income taxes
20,465
17,114
40,310
32,917Net income
$58,456
$45,983
$115,164
$88,085Basic earnings per share
$0.38
$0.31
$0.76
$0.59Diluted earnings per share
$0.37
$0.30
$0.73
$0.57Basic shares outstanding
152,420
150,246
152,006
150,544Diluted shares outstanding
157,593
154,068
157,276
153,748All share and per share information has been adjusted to reflect the two-for-one stock split effected in the form of a 100% stock dividend that was declared on August 5, 2010 and distributed on August 30, 2010.RESMED INC AND SUBSIDIARIESCondensed Consolidated Balance Sheets (Unaudited)
(In US$ thousands except share and per share data)December 31,
June 30,2010
2010ASSETSCurrent assets:Cash and cash equivalents
$616,201
$488,776Accounts receivable, net
235,083
226,911Inventories
214,886
185,642Deferred income taxes
7,447
14,112Income taxes receivable
5,577
5,317Prepaid expenses and other current assets
66,060
64,583Total current assets
1,145,254
<| SOURCE ResMed Inc. Copyright©2010 PR Newswire. All rights reserved |